(Q36742130)

16 August 2017

Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke (English)

1 reference

16 August 2017

1 reference

Steff Lewis

5

0 references

Maria Grazia Celani

Maria Grazia Celani

17

0 references

Martin S Dennis

Martin Dennis

4

0 references

Richard I Lindley

Richard Lindley

2

0 references

Anna Członkowska

Anna Czlonkowska

8

0 references

Graeme J. Hankey

Graeme Hankey

13

0 references

Gord Gubitz

20

Gord Gubitz

1 reference

16 August 2017

3

Joanna Wardlaw

1 reference

16 August 2017

7

Adam Kobayashi

1 reference

ORCID Public Data File 2021

16 August 2017

1 reference

Michael Brainin

15

Michael Brainin

1 reference

16 August 2017

14

Karl Matz

1 reference

16 August 2017

22

Antonio Arauz

1 reference

16 August 2017

25

Phillippe Lyrer

1 reference

16 August 2017

1

Peter Sandercock

1 reference

16 August 2017

IST-3 Collaborative Group

26

IST-3 Collaborative Group

1 reference

16 August 2017

18

Enrico Righetti

1 reference

16 August 2017

Graham Venables

6

1 reference

16 August 2017

Eivind Berge

9

1 reference

16 August 2017

Karsten Bruins Slot

10

1 reference

16 August 2017

Veronica Murray

11

1 reference

16 August 2017

Andre Peeters

12

1 reference

16 August 2017

Stefano Ricci

16

1 reference

16 August 2017

Teresa Cantisani

19

1 reference

16 August 2017

Steve Phillips

21

1 reference

16 August 2017

Kameshwar Prasad

23

1 reference

16 August 2017

Manuel Correia

24

1 reference

16 August 2017

17 June 2008

1 reference

16 August 2017

1 reference

16 August 2017

9

1 reference

16 August 2017

37

1 reference

https://scigraph.springernature.com/pub.10.1186/1745-6215-9-37

16 August 2017

0 references

cites work

A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

What are the components of effective stroke unit care?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Blood pressure and clinical outcomes in the International Stroke Trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Are the modified "simple questions" a valid and reliable measure of health related quality of life after stroke? United Kingdom Collaborators in the International Stroke Trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Tissue plasminogen activator for acute ischemic stroke

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Classification and natural history of clinically identifiable subtypes of cerebral infarction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Hypertension and its treatment in the NINDS rt-PA Stroke Trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Thrombolytic therapy in acute stroke: neurologists, get off your hands!

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Minimization: A new method of assigning patients to treatment and control groups

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Predicting outcome after acute and subacute stroke: development and validation of new prognostic models.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

A randomised comparison of the EuroQol and Short Form-36 after stroke. United Kingdom collaborators in the International Stroke Trial

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442584

A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1745-6215-9-37

Further randomized controlled trials of tissue plasminogen activator within 3 hours are required

21 January 2018

1 reference

12 December 2020

When is enough enough?

1 reference

12 December 2020

Approval of alteplase in Europe: will it change stroke management?

1 reference

12 December 2020

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

12 December 2020

Thrombolytic therapy for acute ischemic stroke

1 reference

12 December 2020

Interobserver agreement for the assessment of handicap in stroke patients

1 reference

12 December 2020

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

12 December 2020

Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals

1 reference

12 December 2020

International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke

1 reference

12 December 2020

Consent to thrombolysis in acute ischaemic stroke: from trial to practice

1 reference

12 December 2020

Identifiers

DOI

10.1186/1745-6215-9-37

1 reference

Dimensions Publication ID

16 August 2017

0 references

1 reference

16 August 2017

PubMed publication ID

18559104

1 reference